Stockscreener 앱 받기
1.765
2.02%
0.035
시간 외 거래:
1.75
-0.015
-0.85%
전일 마감가:
$1.73
열려 있는:
$1.7
하루 거래량:
1.15M
Relative Volume:
2.08
시가총액:
$46.86M
수익:
$80.97M
순이익/손실:
$-78.31M
주가수익비율:
-0.1189
EPS:
-14.85
순현금흐름:
$-129.56M
1주 성능:
-12.62%
1개월 성능:
+8.28%
6개월 성능:
+0.86%
1년 성능:
-21.21%
1일 변동 폭
$1.55
$1.77
1주일 범위
$1.55
$2.07
52주 변동 폭
$1.24
$4.43
Fortress Biotech Inc Stock (FBIO) Company Profile
명칭
Fortress Biotech Inc
전화
781-652-4500
주소
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-15 | 재개 | ROTH MKM | Buy |
| 2022-08-04 | 개시 | Ladenburg Thalmann | Buy |
| 2020-10-02 | 개시 | The Benchmark Company | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2018-02-28 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | 개시 | Rodman & Renshaw | Buy |
| 2017-03-22 | 개시 | JMP Securities | Mkt Outperform |
| 2016-10-03 | 개시 | ROTH Capital | Buy |
모두보기
Fortress Biotech Inc 주식(FBIO)의 최신 뉴스
How To Trade (FBIOP) - Stock Traders Daily
Fortress Biotech Insiders Placed Bullish Bets Worth US$4.49m - Yahoo Finance
Biotech Stocks Facing FDA Decision In November 2024 - RTTNews
Fortress Biotech, Inc.'s (NASDAQ:FBIO) Shares Bounce 36% But Its Business Still Trails The Industry - Simply Wall St
Mustang Bio, Inc. Appoints David Jin as A Member of the Board - Marketscreener.com
Highbridge Capital Management's Strategic Acquisition of Fortress Biotech Shares - Yahoo Finance
Highbridge Capital Management's Strategic Acquisition of Fortres - GuruFocus.com
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference - GlobeNewswire
Mustang Bio secures $4 million from warrant exercises - Investing.com India
Mustang Bio secures $4 million from warrant exercises By Investing.com - Investing.com South Africa
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds - The Manila Times
Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit - The Manila Times
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit - GlobeNewswire
Analysts review Fortress Biotech Inc’s rating - Knox Daily
Was there any good news for Fortress Biotech Inc (FBIO) stock in the last session? - US Post News
PRESIDENT, CEO & CHAIRMAN ROSENWALD LINDSAY A MD acquire 763,359 shares of Fortress Biotech Inc [FBIO] - Knox Daily
Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewswire
Fortress Biotech Inc (FBIO) expanding its growth trajectory ahead - SETE News
Nantahala Capital Management LLC Sells 125,000 Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
PVG Asset Management Corp Invests $266,000 in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
Fortress Biotech Inc (FBIO) receives a Buy rating from ROTH MKM - Knox Daily
Fortress Biotech Inc (FBIO)’s results reveal risk - US Post News
Fortress Biotech Inc (FBIO)’s Market Momentum: Closing Strong at 1.49, Up 2.76 - The Dwinnex
(FBIOP) Investment Analysis and Advice - Stock Traders Daily
Lawsuit filed for Investors who lost money with shares of New Fortress Energy Inc. (NASDAQ: NFE) - openPR
Fortress Biotech Inc [FBIO] Shares Rise 1.44 % on Wednesday - Knox Daily
FBIOFortress Biotech, Inc. Latest Stock News & Market Updates - StockTitan
Fortress Biotech to Participate in October 2024 Investor Conferences - The Manila Times
Insider Buying at Fortress Biotech Inc (FBIO): President, CEO & - GuruFocus.com
Fortress Biotech CEO acquires $1.4m in company stock By Investing.com - Investing.com Australia
Fortress Biotech CEO acquires $1.4m in company stock - Investing.com
This trade activity should not be overlooked: Fortress Biotech Inc (FBIO) - SETE News
Fortress Biotech Inc (FBIO) shows promising results - US Post News
NexPoint Responds to United Development Funding IV's (UDF IV) Misleading Claims - Quantisnow
Investing in Fortress Biotech Inc (FBIO) Is Getting More Attractive - Knox Daily
Ratios Revealed: Decoding Fortress Biotech Inc (FBIO)’s Financial Health - The Dwinnex
Fortress Biotech secures $8 million in stock sales - Investing.com
Fortress Biotech Inc Inc. (FBIO) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
A look at FBIO’s current quarter earnings estimates - US Post News
Why Fortress Biotech (FBIO) Stock Is Getting Hammered - Benzinga
Fortress Biotech to sell 3.9M shares at $1.65 in registered direct offering - MSN
Fortress Biotech secures $8 million in stock sales By Investing.com - Investing.com Australia
Fortress Biotech (FBIO) Prices 3.94M Sharee Offering at $1.65/sh - StreetInsider.com
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements - GlobeNewswire
Fortrea Holdings Inc. (NASDAQ:FTRE) Shares Bought by Mutual of America Capital Management LLC - Defense World
Checkpoint Therapeutics Announces Cosibelimab Longer-Term - GlobeNewswire
Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024 - StockTitan
Mustang Bio faces Nasdaq delisting over equity shortfall - Investing.com India
Journey Medical Corporation to Participate in the Lake - GlobeNewswire
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference - StockTitan
Fortress Biotech Inc (FBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fortress Biotech Inc 주식 (FBIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ROSENWALD LINDSAY A MD | President, CEO & Chairman |
Jul 11 '24 |
Buy |
7.48 |
5,000 |
37,418 |
127,500 |
| Jin David | Chief Financial Officer |
Jul 10 '24 |
Buy |
7.50 |
500 |
3,750 |
500 |
| ROSENWALD LINDSAY A MD | President, CEO & Chairman |
Jul 09 '24 |
Buy |
7.39 |
5,000 |
36,971 |
122,500 |
| ROSENWALD LINDSAY A MD | President, CEO & Chairman |
Jul 08 '24 |
Buy |
7.35 |
5,000 |
36,764 |
117,500 |
| ROSENWALD LINDSAY A MD | President, CEO & Chairman |
Jun 28 '24 |
Buy |
1.64 |
20,000 |
32,724 |
2,893,905 |
| ROSENWALD LINDSAY A MD | President, CEO & Chairman |
May 16 '24 |
Buy |
1.76 |
10,000 |
17,589 |
2,873,905 |
| Klein Dov | Director |
May 20 '24 |
Sale |
1.89 |
10,000 |
18,900 |
53,400 |
| ROSENWALD LINDSAY A MD | President, CEO & Chairman |
Jan 05 '24 |
Buy |
2.38 |
50,000 |
118,770 |
2,863,905 |
| ROSENWALD LINDSAY A MD | President, CEO & Chairman |
Nov 14 '23 |
Buy |
1.70 |
1,567,515 |
2,664,776 |
2,597,440 |
| WEISS MICHAEL S | See Remarks |
Nov 14 '23 |
Buy |
1.70 |
147,058 |
249,999 |
1,130,520 |
2.02%
0.47%
자본화:
|
볼륨(24시간):